Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck under formal investigation in France over Thyroid Drug Levothyrox

Ruchika Sharma20 Oct 2022 2:30 PM IST

Paris: Drugmaker Merck said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information...

Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab Biotech

Syrup, liquid medicines banned in Indonesia after deaths of nearly 100 children

Ruchika Sharma20 Oct 2022 1:30 PM IST

The Indonesian food and drugs agency said the syrups imported into The Gambia were not available in the Southeast Asian country.

DNB Biochemistry in India: Check out NBE released Curriculum

Ruchika Sharma20 Oct 2022 1:16 PM IST

The National Board of Examinations (NBE) has released the Curriculum for DNB Biochemistry. The postgraduate courses in Biochemistry should enable...

Lupin to acquire two inhalation medicines from Sunovion Pharma for over Rs 623 crore

Ruchika Sharma20 Oct 2022 12:15 PM IST

Brovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

Lupin gets 17 USFDA observations for Pune facility

Ruchika Sharma20 Oct 2022 11:20 AM IST

"The Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility," Lupin stated.

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Lilly to acquire Akouos for Hearing Loss treatments

Ruchika Sharma19 Oct 2022 3:30 PM IST

Under the terms of the transaction, Lilly will acquire all of the outstanding shares of Akouos for $12.50 per share in cash, plus one contingent value...

SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal Vaccine

Serum Institute of India plans to manufacture Ebola vaccine for use in Uganda outbreak

Ruchika Sharma19 Oct 2022 2:30 PM IST

The source said the Ebola vaccine doses would be supplied free of cost.

Money laundering case: Surya Pharma properties worth Rs 185 crore attached by ED

Ruchika Sharma19 Oct 2022 1:30 PM IST

PMLA Investigation revealed that the modus operandi of the said fraud was availing Letter of Credits (LCs) in lieu of bogus invoices and discounting...

Alembic Pharma gets four USFDA observations for Panelav facility

Alembic Pharma Panelav facility gets 4 USFDA observations

Ruchika Sharma19 Oct 2022 12:00 PM IST

Vadodara: Drugmaker, Alembic Pharma, has recently announced that the United States Food and Drug Administration (USFDA) has issued a Form 483 with 4...

Baxter Pharma India sets up global Pharmaceuticals RnD Centre in Ahmedabad

Ruchika Sharma19 Oct 2022 11:00 AM IST

The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical...

Ajanta Pharma conferred as "Best Managed Companies" in India by Deloitte

Ruchika Sharma18 Oct 2022 2:30 PM IST

Mumbai: Ajanta Pharma, a specialty pharmaceutical formulation company, has been awarded as "Best Managed Companies" in India by Deloitte for 2022. ...

USFDA nod to JnJ Tremfya for Crohns disease

JnJ sells Telangana plant to Hetero for Rs 130 crore

Ruchika Sharma18 Oct 2022 1:30 PM IST

The facility will be Hetero's flagship sterile pharmaceutical and biologics manufacturing unit and will generate 2,000 new jobs, Hetero said in a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok